Aho Inka, Kivelä Pia, Haukka Jari, Sutinen Jussi, Heikinheimo Oskari
Infectious Diseases, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Department of Public Health, University of Helsinki, Helsinki, Finland.
Acta Obstet Gynecol Scand. 2017 Nov;96(11):1330-1337. doi: 10.1111/aogs.13207. Epub 2017 Sep 19.
Cervical screening by means of annual Papanicolaou (PAP) smears has been recommended for all women living with HIV. We analysed the results of our annual PAP smear screening program to identify low-risk subgroups for less rigorous screening.
The study comprised 369 women followed at the Helsinki University Hospital 2002-2013, with a total of 2033 PAP smear results. We analyzed the temporal changes in PAP smear findings. Logistic regression analysis for binominal dependent variables was used for assessing risk factors for ever having cytological squamous intraepithelial lesions (hereafter referred as SIL) using generalized estimating equations taking into account multiple observations of each patient.
Most women had well-controlled HIV, especially towards the end of the study. PAP smear results improved substantially. At the time of each individual's last PAP smear, 90.0% of the findings displayed normal results. Conversely, the rate of SIL decreased from 16.8% to 4.6% from 2002 to 2013. In multivariate analysis the risk of SIL was significantly lower in women with consecutive normal PAP smear findings during the first two years of follow up [odds ratio (OR) 0.21, 95% confidence interval (CI) 0.10-0.45, p < 0.001] and with CD4 counts >500 cells/μL (OR 0.11, 95% CI 0.05-0.26, p < 0.001).
Widespread use of combination antiretroviral therapy (cART) and systematic cervical screening has reduced the rate of abnormal PAP smears. It seems feasible to identify low-risk women by combining HIV-related information and PAP smear results. Screening low-risk women living with HIV at three-year intervals similar to HIV-negative women appears justified.
对于所有感染艾滋病毒的女性,建议每年进行巴氏涂片检查以进行宫颈癌筛查。我们分析了年度巴氏涂片筛查项目的结果,以确定可采用较宽松筛查方式的低风险亚组。
该研究纳入了2002年至2013年在赫尔辛基大学医院接受随访的369名女性,共有2033次巴氏涂片检查结果。我们分析了巴氏涂片检查结果随时间的变化。对于二项分类因变量,采用逻辑回归分析,使用广义估计方程评估发生细胞学鳞状上皮内病变(以下简称SIL)的危险因素,同时考虑了每位患者的多次观察结果。
大多数女性的艾滋病毒得到了良好控制,尤其是在研究接近尾声时。巴氏涂片检查结果有了显著改善。在每个人最后一次巴氏涂片检查时,90.0%的检查结果显示正常。相反,2002年至2013年期间,SIL的发生率从16.8%降至4.6%。在多变量分析中,在随访的前两年连续巴氏涂片检查结果正常的女性发生SIL的风险显著较低[比值比(OR)0.21,95%置信区间(CI)0.10 - 0.45,p < 0.001],CD4细胞计数>500个/μL的女性也是如此(OR 0.11,95% CI 0.05 - 0.26,p < 0.001)。
联合抗逆转录病毒疗法(cART)的广泛应用和系统性宫颈癌筛查降低了巴氏涂片异常的发生率。通过结合艾滋病毒相关信息和巴氏涂片检查结果来识别低风险女性似乎是可行的。对于感染艾滋病毒的低风险女性,每三年进行一次筛查,类似于艾滋病毒阴性女性,似乎是合理的。